These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 34007460)

  • 1. Control theory helps to resolve the measles paradox.
    Anelone AJN; Hancock EJ; Klein N; Kim P; Spurgeon SK
    R Soc Open Sci; 2021 Apr; 8(4):201891. PubMed ID: 34007460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling the measles paradox reveals the importance of cellular immunity in regulating viral clearance.
    Morris SE; Yates AJ; de Swart RL; de Vries RD; Mina MJ; Nelson AN; Lin WW; Kouyos RD; Griffin DE; Grenfell BT
    PLoS Pathog; 2018 Dec; 14(12):e1007493. PubMed ID: 30592772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Canine Distemper Virus Spread and Transmission to Naive Ferrets: Selective Pressure on Signaling Lymphocyte Activation Molecule-Dependent Entry.
    Sawatsky B; Cattaneo R; von Messling V
    J Virol; 2018 Aug; 92(15):. PubMed ID: 29793948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morbillivirus Experimental Animal Models: Measles Virus Pathogenesis Insights from Canine Distemper Virus.
    da Fontoura Budaszewski R; von Messling V
    Viruses; 2016 Oct; 8(10):. PubMed ID: 27727184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The antigenic relationship between measles, canine distemper and rinderpest viruses studied with monoclonal antibodies.
    Sheshberadaran H; Norrby E; McCullough KC; Carpenter WC; Orvell C
    J Gen Virol; 1986 Jul; 67 ( Pt 7)():1381-92. PubMed ID: 2425047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specificity of Morbillivirus Hemagglutinins to Recognize SLAM of Different Species.
    Fukuhara H; Ito Y; Sako M; Kajikawa M; Yoshida K; Seki F; Mwaba MH; Hashiguchi T; Higashibata MA; Ose T; Kuroki K; Takeda M; Maenaka K
    Viruses; 2019 Aug; 11(8):. PubMed ID: 31430904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The hemagglutinin envelope protein of canine distemper virus (CDV) confers cell tropism as illustrated by CDV and measles virus complementation analysis.
    Stern LB; Greenberg M; Gershoni JM; Rozenblatt S
    J Virol; 1995 Mar; 69(3):1661-8. PubMed ID: 7853502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measles vaccination: Threat from related veterinary viruses and need for continued vaccination post measles eradication.
    Cosby SL; Weir L
    Hum Vaccin Immunother; 2018 Jan; 14(1):229-233. PubMed ID: 29173050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New world origin of canine distemper: Interdisciplinary insights.
    Uhl EW; Kelderhouse C; Buikstra J; Blick JP; Bolon B; Hogan RJ
    Int J Paleopathol; 2019 Mar; 24():266-278. PubMed ID: 30743216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Canine distemper virus (CDV) immune-stimulating complexes (Iscoms), but not measles virus iscoms, protect dogs against CDV infection.
    De Vries P; Uytdehaag FG; Osterhaus AD
    J Gen Virol; 1988 Aug; 69 ( Pt 8)():2071-83. PubMed ID: 3404123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Canine distemper virus (CDV) infection of ferrets as a model for testing Morbillivirus vaccine strategies: NYVAC- and ALVAC-based CDV recombinants protect against symptomatic infection.
    Stephensen CB; Welter J; Thaker SR; Taylor J; Tartaglia J; Paoletti E
    J Virol; 1997 Feb; 71(2):1506-13. PubMed ID: 8995676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological properties of phocine distemper virus and canine distemper virus.
    Blixenkrone-Møller M
    APMIS Suppl; 1993; 36():1-51. PubMed ID: 8268007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The morbillivirus receptor SLAM (CD150).
    Tatsuo H; Yanagi Y
    Microbiol Immunol; 2002; 46(3):135-42. PubMed ID: 12008921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Limited contribution of humoral immunity to the clearance of measles viremia in rhesus monkeys.
    Permar SR; Klumpp SA; Mansfield KG; Carville AA; Gorgone DA; Lifton MA; Schmitz JE; Reimann KA; Polack FP; Griffin DE; Letvin NL
    J Infect Dis; 2004 Sep; 190(5):998-1005. PubMed ID: 15295708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Special Issue "Recent Advances in Morbillivirus Vaccine Development and Oncolytic Virotherapy".
    Lin LT
    Viruses; 2020 Mar; 12(3):. PubMed ID: 32245003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measles virus and inactivated canine distemper virus induce incomplete immunity to canine distemper.
    Appel MJ; Shek WR; Shesberadaran H; Norrby E
    Arch Virol; 1984; 82(1-2):73-82. PubMed ID: 6497659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection against morbillivirus-induced encephalitis by immunization with a rationally designed synthetic peptide vaccine containing B- and T-cell epitopes from the fusion protein of measles virus.
    Obeid OE; Partidos CD; Howard CR; Steward MW
    J Virol; 1995 Mar; 69(3):1420-8. PubMed ID: 7531779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune-Mediated Control of a Dormant Neurotropic RNA Virus Infection.
    Miller KD; Matullo CM; Milora KA; Williams RM; O'Regan KJ; Rall GF
    J Virol; 2019 Sep; 93(18):. PubMed ID: 31270232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Approaches in the understanding of morbillivirus neurovirulence.
    Cosby SL; Duprex WP; Hamill LA; Ludlow M; McQuaid S
    J Neurovirol; 2002 Dec; 8 Suppl 2():85-90. PubMed ID: 12491157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Receptor (SLAM [CD150]) recognition and the V protein sustain swift lymphocyte-based invasion of mucosal tissue and lymphatic organs by a morbillivirus.
    von Messling V; Svitek N; Cattaneo R
    J Virol; 2006 Jun; 80(12):6084-92. PubMed ID: 16731947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.